Research
Hormonal
GLP-1 receptor agonists (GLP1RAs) produce significant weight loss and glycemic control in type 2 diabetes and obesity, with efficacy varying by specific agent, dose, and formulation.
If you have obesity or type 2 diabetes, GLP-1 drugs like semaglutide can help you lose significant weight and control blood sugar. You take it once a week. Side effects like nausea are common at first but usually go away. It works best when combined with healthy eating and exercise.
GoodSupportsHIGH confidence
GLP1RAs are becoming a popular treatment option for people with T2DM due to their multiple benefits, such as their ability to lower glycated haemoglobin levels and reduce weight and their low risk of causing hypoglycaemia
Why this rating
Based on multiple phase 3 trials (SUSTAIN, STEP, LEADER) and CVOTs cited.
Source
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
Sanjay Kalra et al. · Diabetes Therapy · 2021
DOI 10.1007/s13300-021-01113-y
narrative_reviewCited 37×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Tirzepatide, a dual GIP/GLP-1 receptor agonist, produces dose-dependent weight loss and glycemic control, often superior to other GLP-1 agents.Good
- Fixed-ratio combinations of GLP-1 receptor agonists and basal insulin provide superior glycemic control and weight loss compared to insulin alone, without increasing hypoglycemia risk.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →